Curative Biotechnology, Inc. (OTCMKTS:CUBTD – Get Free Report)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $1.10, but opened at $1.05. Curative Biotechnology shares last traded at $1.05, with a volume of 100 shares traded.
Curative Biotechnology Price Performance
The stock’s 50 day simple moving average is $1.10 and its two-hundred day simple moving average is $1.08.
About Curative Biotechnology
Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc to develop the COVID-19 vaccine.
See Also
Receive News & Ratings for Curative Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curative Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
